Curator's Take
This article represents a significant milestone in quantum computing's march toward real-world applications, as Infleqtion demonstrates 12 logical qubits successfully running biomarker discovery algorithms on their neutral-atom platform. What makes this particularly noteworthy is the convergence of quantum error correction achieving double-digit logical qubits with a genuine biological application, moving beyond toy problems to tackle actual drug discovery challenges. The $2M Wellcome Leap funding and collaboration with top-tier institutions like UChicago and MIT signals serious investment in quantum advantage for life sciences, an area where quantum computing's pattern recognition capabilities could revolutionize how we identify disease biomarkers and develop targeted therapies.
— Mark Eatherly
Summary
Infleqtion reported technical results from its Q4Bio project, involving the executing biomarker discovery algorithms using 12 logical qubits on its Sqale neutral-atom quantum computer. Supported by a $2M Phase III contract from Wellcome Leap and conducted in collaboration with academic partners at UChicago and MIT, the project integrates a hybrid quantum-classical workflow to identify high-impact [...] The post Infleqtion Achieves 12-Logical-Qubit Milestone for Q4Bio Biomarker Discovery appeared first on Quantum Computing Report .